Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza and Curcumin C3 Complex for Lung Nodule Reduction
NCT03598309Phase 2Active, not recruiting
- Sponsor
- Moffitt Cancer Center
- Start
- Jun 2019
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eicosapentaenoic acid + docosahexaenoic acid, Curcuminoids C3 Complex in lung cancer, sponsored by Moffitt Cancer Center. Started Jun 2019; status: active, not recruiting.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acidCurcuminoids C3 Complex
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT03598309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598309.